Releasing potential. Developing people. Providing the right tools.
Giving it everything. Making it enjoyable. Knowing why your work is important.
Bio-Techne Corporation (NASDAQ: TECH ) today announced the introduction of MitoBrilliant ™ probes.
Dec 5, 2022 | prnewswire.comMINNEAPOLIS, Oct. 12, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH ) today announced the introduction of 3 novel TSA Vivid Fluorophores for highly sensitive fluorescent detection of RNAs and proteins in cells and tissues.
Oct 12, 2022 | prnewswire.comBio-Techne introduced the Simple Plex AAV2 assay in co-operation with PROGEN last year, the first in its series of AAV assays for the reliable quantification of AAV capsid titers.
Oct 10, 2022 | instrumentbusinessoutlook.comIn September 2021, Bio-Techne Corporation developed a new medium ExCellerate IpsC expansion medium, for IpsC research in regenerative medicine.
Sep 28, 2022 | reportedtimes.comBio-Techne Corporation has announced an agreement with Thermo Fisher Scientific to exclusively complete development of and commercialize the ExoTRU kidney transplant rejection test developed by Exosome Diagnostics, a Bio-Techne brand.
Feb 23, 2022 | biospectrumindia.comBio-Techne Corporation (NASDAQ: TECH ) today announced an agreement with Thermo Fisher Scientific to exclusively complete development of and commercialize the ExoTRU kidney transplant rejection test developed by Exosome Diagnostics, a Bio-Techne brand.
Jan 1, 2022 | prnewswire.comProteinSimple recently merged with Bio-Techne, and is now a part of the company’s Protein Platforms division.
Jan 1, 2022 | excedr.comSimilarly, in 2020, Bio-Techne Corporation partnered with Elpiscience BioPharma with the objective of advancing anticancer therapeutics.
Jan 1, 2022 | themobility.clubFor instance, Bio-Techne Corporation, in October 2020, launched a SARS-CoV-2 multi-antigen module for Simple Western and Jess automated western blotting systems.
Jan 1, 2022 | riponcollegedays.comBio-Techne Corporation (NASDAQ: TECH) today announced that it has been included on the Forbes list of Best Employers for Diversity 2022.
Jan 1, 2022 | bio-techne.comBio-Techne Corporation (NASDAQ: TECH ) and Cygnus Technologies, part of Maravai LifeSciences (NASDAQ: MRVI ), announced today the launch of the Simple Plex™ HEK 293 HCP 3G assay for automated process impurity testing on the Ella™ immunoassay platform.
Jan 1, 2022 | prnewswire.comOn the human capital front, Bio-Techne received two important awards during the third quarter.
Jan 1, 2022 | seekingalpha.comCharles Kummeth became President and Chief Executive Officer of Bio-Techne Corporation on April 1, 2013.
Jan 1, 2022 | twst.comBio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc.
Jan 1, 2022 | bio-techne.comBio-Techne launches Abby automated western system Bio-Techne announced that its brand ProteinSimple has released Abby, its next-generation chemiluminescence system that automates traditional western blotting.
Jan 1, 2021 | scienceboard.netNew York-based Morgan Stanley has invested 0.01% in Bio-Techne Corporation (NASDAQ:TECH).
Jan 1, 2018 | whatsonthorold.comBio-Techne has agreed to buy Exosome Diagnostics, a Massachusetts company whose technology tests for disease by scanning body fluids, for $250 million in cash.
Jan 1, 2018 | bizjournals.com